Duncan NRI RNA Therapeutic Discovery Platform
Antisense Oligonucleotides (ASO): Cutting-Edge Therapeutic Options for Neurological Disorders
The Duncan NRI and Baylor College of Medicine have partnered with La Jolla Labs to make a new research tool available to the Texas Children's and Baylor communities.
With access to La Jolla Labs' cutting-edge RNA Therapeutics Discovery Platform (BCM login required), researchers can design antisense oligonucleotides (ASO) targeting genes of interest to modulate their expression. This powerful platform allows researchers to efficiently design strategies for gene splicing targets as well.
